Probiotic Product Portfolio
A curated portfolio of probiotic strains spanning gut, immune, cardiometabolic, oral and urogenital health, supplied across two delivery platforms, spore-forming and freeze-dried, in the formats you formulate in.
Flagship strains
Two strains in the portfolio carry published, placebo-controlled evidence for a specific indication, then characterised and documented.
Lactobacillus reuteri NCIMB 30242
Selected from 350+ candidate strains for its exceptional bile-salt-hydrolase activity.
Lactobacillus acidophilus LA-5
A clinically documented single strain supporting women's urogenital health: balanced vaginal microbiota, normal yeast levels and urinary-tract health, with an emotional well-being benefit.
3 clinical studies · Borhani 2025 · Hilton 1992 · Mollazadeh-Narestan 2022
View strain details →Standard portfolio
Spore-forming strains ship ambient and survive processing; freeze-dried lactobacilli carry the highest counts. Each strain is marked by its platform.
Dormant spores that stay viable through manufacturing, so they suit formats other probiotics can't survive.
High-count freeze-dried lactobacilli for capsule, stick and powder formats.
Sourcing
Tell us the strain, the count and the format you need. We source to your specification and supply the documentation with it: specification sheets, COA and regulatory dossiers included.
We use essential cookies to remember your theme preference and enable our contact forms. With your consent, we also use analytics and marketing cookies to understand how the site is used and improve it. You can decline the non-essential ones. See our Privacy Policy.